Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06568588
PHASE2

Effects of Probiotic Consumption in Children With Autism Spectrum Disorder (ASD)

Sponsor: Universidad San Francisco de Quito

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to determine the effects of Saccharomyces boulardii (Sb) consumption on Ecuadorian children with a diagnosis of autism spectrum disorder (ASD) and digestive symptoms. Saccharomyces boulardii is a probiotic, in other words, a beneficial microorganism. The main question it aims to answer is: Does Sb improve intestinal health, defenses against infections, nutrition and behavior of the participants. Researchers will compare children when they are taking and not taking Saccharomyces boulardii to know if there are changes in digestive symptoms, immune system function, nutritional status and behavior. Participants will take Saccharomyces boulardii for 4 months and will be 4 months without taking Sb. All participants must provide stool, urine and blood samples. A medical, nutritional and psychological team will follow the participants at least 5 times during the study.

Official title: Effects of Probiotic Consumption in Children With Autism Spectrum Disorder (ASD) in the Metropolitan District of Quito, Ecuador

Key Details

Gender

All

Age Range

5 Years - 12 Years

Study Type

INTERVENTIONAL

Enrollment

66

Start Date

2024-01-06

Completion Date

2026-08

Last Updated

2026-01-15

Healthy Volunteers

No

Interventions

DRUG

S. boulardii CNCM (National Collection of Cultures of Microorganisms) I-745

250 mg three times a day for 4 months

Locations (1)

Neurodesarrollo Quito

Quito, Pichincha, Ecuador